TRANSLARNA
Live / Applied — Second extension granted (statement of use) (as of 21 Oct 2025)
What this means for you
Not registered yet, but its 01 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98386919
- Mark type
- Stylized text
- Filed
- 01 Feb 2024
- Published for opposition
- 27 Aug 2024
- Attorney of record
- Alexandria P. Stiteler
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic disorders
Owner
- PTC Therapeutics, Inc., Warren, NJ, US
- PTC Therapeutics, Inc., Warren, NJ, US
Prosecution history
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Oct 2025 — SOU EXTENSION 2 GRANTED
- 21 Oct 2025 — SOU EXTENSION 2 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Apr 2025 — SOU EXTENSION 1 GRANTED
- 15 Apr 2025 — SOU EXTENSION 1 FILED
- 15 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Aug 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Aug 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED